Causaly

Two people in a laboratory looking at a tablet with beakers behind them

Causaly scores $60M to enhance AI platform for biomedical research

By Jessica Hagen 12:30 pm July 13, 2023

Causaly, a tech company using AI to interpret large datasets and literature, announced it closed a $60 million Series B round led by ICONIQ Growth. Marathon Venture Capital, Index Ventures, Pentech Ventures, EBRD and Visionaries Club also participated in the round, as did former chairman and CEO of Johnson & Johnson Alex Gorsky and CEO and cofounder of Datadog Olivier Pomel. WHAT IT DOES...

Aetion, HealthVerity collaborate on real-world data for COVID-19 treatments, Aptar Pharma, Sonmol co-developing digital respiratory offerings and more digital health deals

By Dave Muoio 02:54 pm April 22, 2020

Real-world evidence platforms Aetion and HealthVerity are playing to their strengths with the joint launch of new tools to support biopharmas and regulators gauging new COVID-19 treatments. The first, called the Real-Time Evidence Platform, is built on an instance of Aetion's platform and focuses on up-to-date usage, safety and effectiveness data. The Real-Time Trend Reporting and Interactive...